Group One Trading
TENX icon

Group One Trading’s Tenax Therapeutics TENX Stock Holding History

Group One Trading’s Portfolio TENX Stock Details TENX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Hold
0
– – – 5401
2018
Q3 		– Hold
0
– – – 5603
2018
Q2 		– Hold
0
– – – 5472
2018
Q1 		– Hold
0
– – – 5298
2017
Q3 		– Hold
0
– -$10K – 5159
2017
Q2 		– Sell
-1
Closed -$16.6K – 4217
2017
Q1 		$10K Buy
+1
New +$36.3K ﹤0.01% 4121
2016
Q4 		– Hold
0
– – – 3548
2014
Q4 		– Sell
-5
Closed -$605K – 5264
2014
Q3 		$587K Buy
5
+3
+150% +$385K 0.01% 1504
2014
Q2 		$228K Buy
+2
New +$308K ﹤0.01% 2288
2014
Q1 		– Hold
0
– – – 4683

Other funds holding TENX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
SM
Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
FWP
FAS Wealth Partners Leawood, Kansas $1.61B AUM 19.97% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Group One Trading's TENX Position: Q4 2018 in Review

Group One Trading held its Tenax Therapeutics (TENX) position steady in Q4 2018 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #5401.

Group One Trading first reported a position in TENX in Q2 2014 and has held it in 3 quarters since. The position peaked at $587K in Q3 2014. 9 funds tracked by Wall St. Rank hold TENX as of Q4 2018.

  • Group One Trading held 0 shares of Tenax Therapeutics worth $0 as of Q4 2018.
  • Group One Trading left its Tenax Therapeutics share count unchanged in Q4 2018.
  • Tenax Therapeutics made up ﹤0.01% of Group One Trading's portfolio in Q4 2018, its #5401 holding.
  • Group One Trading first reported a position in Tenax Therapeutics in Q2 2014 and has held it in 3 quarters since.
  • Group One Trading's Tenax Therapeutics position peaked at $587K in Q3 2014.
  • 9 funds tracked by Wall St. Rank held Tenax Therapeutics as of Q4 2018.

Based on Group One Trading's 13F filing for Q4 2018, filed 6 Feb 2019.